MORPHOGEN-IX LIMITED
CAMBRIDGE

Hellopages » Cambridgeshire » South Cambridgeshire » CB22 3AT

Company number 09686738
Status Active
Incorporation Date 15 July 2015
Company Type Private Limited Company
Address MONETA BUILDING, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, ENGLAND, CB22 3AT
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration fourteen events have happened. The last three records are Change of share class name or designation; Director's details changed for Dr Kevin Stuart Johnson on 20 September 2016; Director's details changed for Dr David John Grainger on 20 September 2016. The most likely internet sites of MORPHOGEN-IX LIMITED are www.morphogenix.co.uk, and www.morphogen-ix.co.uk. The predicted number of employees is 30 to 40. The company’s age is ten years and five months. The distance to to Shelford (Cambs) Rail Station is 3 miles; to Cambridge Rail Station is 5.2 miles; to Audley End Rail Station is 8.9 miles; to Waterbeach Rail Station is 9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Morphogen Ix Limited is a Private Limited Company. The company registration number is 09686738. Morphogen Ix Limited has been working since 15 July 2015. The present status of the company is Active. The registered address of Morphogen Ix Limited is Moneta Building Babraham Research Campus Cambridge England Cb22 3at. The company`s financial liabilities are £1008k. It is £1008k against last year. The cash in hand is £922.94k. It is £922.94k against last year. And the total assets are £1094.04k, which is £1094.04k against last year. THE CAMBRIDGE PARTNERSHIP LIMITED is a Secretary of the company. GRAINGER, David John, Dr is a Director of the company. JOHNSON, Kevin Stuart, Dr is a Director of the company. MORELL, Nicholas, Professor is a Director of the company. TANSLEY, Robert Giles, Dr is a Director of the company. WALSH, Andrew Peter is a Director of the company. The company operates in "Research and experimental development on biotechnology".


morphogen-ix Key Finiance

LIABILITIES £1008k
CASH £922.94k
TOTAL ASSETS £1094.04k
All Financial Figures

Current Directors

Secretary
THE CAMBRIDGE PARTNERSHIP LIMITED
Appointed Date: 15 July 2015
Director
GRAINGER, David John, Dr
Appointed Date: 15 July 2015
59 years old
Director
JOHNSON, Kevin Stuart, Dr
Appointed Date: 30 October 2015
65 years old
Director
MORELL, Nicholas, Professor
Appointed Date: 30 October 2015
63 years old
Director
TANSLEY, Robert Giles, Dr
Appointed Date: 30 October 2015
61 years old
Director
WALSH, Andrew Peter
Appointed Date: 30 October 2015
57 years old

MORPHOGEN-IX LIMITED Events

20 Dec 2016
Change of share class name or designation
23 Sep 2016
Director's details changed for Dr Kevin Stuart Johnson on 20 September 2016
23 Sep 2016
Director's details changed for Dr David John Grainger on 20 September 2016
18 Jul 2016
Confirmation statement made on 14 July 2016 with updates
25 Jan 2016
Registered office address changed from C/O Index Ventures (Uk) Llp 3 Burlington Gardens Mayfair London W1S 3EP England to Moneta Building Babraham Research Campus Cambridge CB22 3AT on 25 January 2016
...
... and 4 more events
26 Nov 2015
Appointment of Professor Nicholas Morell as a director on 30 October 2015
24 Nov 2015
Statement of capital following an allotment of shares on 3 November 2015
  • GBP 19,589.56
24 Nov 2015
Change of share class name or designation
24 Nov 2015
Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
15 Jul 2015
Incorporation
Statement of capital on 2015-07-15
  • GBP .01

Similar Companies

MORPHOGENE CONSULTING LIMITED MORPHOGENESIS LIMITED MORPHOLIFE LIMITED MORPHOLOGICAL LTD MORPHOLOGY CAPITAL PARTNERS LIMITED MORPHOLOGY CONSULTANTS LIMITED MORPHOLOGY CONSULTING LTD